By Saumya Joseph (Reuters) – Amarin Corp Plc’s fish oil-derived drug received a largely positive review from FDA staffers on Tuesday, dispelling investor fears that the company’s choice of placebo in its trial...
Read MoreBy Manojna Maddipatla (Reuters) – Shares in Solid Biosciences Inc plunged 71% on Tuesday after a trial testing its gene therapy for a muscle-wasting disorder was halted for the second time in less than two years. A...
Read More
TOKYO (Reuters) – Japan Tobacco is halving the price of starter kits for its Ploom S...
Read More
By Paresh Dave SAN FRANCISCO (Reuters) – Alphabet Inc’s <GOOGL.O> Google has...
Read More
By Kate Kelland LONDON (Reuters) – Pneumonia killed more than 800,000 babies and young...
Read More
By Richa Naidu CHICAGO (Reuters) – Burger King on Monday rolled out a meat-free version of...
Read MoreBy Lisa Rapaport (Reuters Health) – U.S. hospitals’ sticker prices for two common sources of surprise medical bills have climbed far faster than economic inflation, a new study suggests. Researchers focused on...
Read MoreBy Lisa Rapaport (Reuters Health) – Families of dying patients may feel better about end-of-life care in the ICU if they are granted simple wishes, like letting the patient taste a favorite meal or use a blanket from home,...
Read MoreBy Lisa Rapaport (Reuters Health) – Only about 60% of lung cancer patients get recommended treatments like chemotherapy and radiation that are linked to better survival odds, and a new study suggests rates are even lower...
Read More
WASHINGTON (Reuters) – U.S. President Donald Trump said on Monday he will be meeting with...
Read More
BERLIN (Reuters) – Snack maker Mondelez <MDLZ.O> will offer more treats in smaller...
Read MoreBy Linda Carroll (Reuters Health) – Primary care providers often don’t realize that hair care can be a barrier to regular exercise for some black women, a new study suggests. Hair care routines aren’t a barrier...
Read More
(Reuters) – U.S. drugmaker Merck & Co Inc on Monday received approval from the European...
Read More
(Reuters) – AstraZeneca Plc said on Monday its experimental treatment significantly reduced...
Read MoreLAGOS (Reuters) – Thousands of people with mental health conditions are held in chains in institutions across Nigeria, Human Rights Watch said in a report published on Monday in which it urged the government to ban the...
Read MoreBy Reuters Staff ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved motor function in...
Read More
ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal...
Read More
ZURICH (Reuters) – Roche is testing its “brain shuttle” in humans, with the...
Read More(Reuters) – The U.S. Food and Drug Administration on Monday declined to approve Lipocine Inc’s oral drug to treat a condition that results in lower production of male sex hormone for the third time, sending the drug...
Read More(Reuters) – One new case of measles was reported this weekend in the United States, with the country suffering its worst outbreak of the highly contagious and sometimes deadly disease in close-to three decades. The measles...
Read More
